Edarbi (azilsartan medoxomil is during a cluster of medication referred to as angiotensin II receptor antagonists. Edarbi keeps blood vessels from narrowing, that lowers vital sign and improves blood flow.
Edarbi is employed to treat high vital sign (hypertension). it’s typically given at the side of different vital signmedications.
Edarbi can also be used for functions unlisted during this medication guide.
Submit your review
Get emergency medical help if you have any of these signs of an allergic reaction to Edarbi: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:
feeling like you might pass out;
urinating less than usual or not at all;
drowsiness, confusion, mood changes, increased thirst, loss of appetite, vomiting; or
swelling, weight gain, feeling short of breath.
Less serious Edarbi side effects may include:
diarrhea, mild nausea;
mild dizziness; or
weakness, tired feeling.
Initial dose: 80 mg orally once daily. It may be appropriate to initiate dosage at 40 mg orally once daily for patients who are treated with high doses of diuretics. Maintenance dose: 80 mg orally once daily